key: cord-0916150-zrg2z17n
authors: Marik, Paul E.; Kory, Pierre; Varon, Joseph
title: Does vitamin D status impact mortality from SARS-CoV-2 infection?
date: 2020-04-29
journal: Med Drug Discov
DOI: 10.1016/j.medidd.2020.100041
sha: cba8e6ca66a77a018dd33acafa1f06d9b3fa98d1
doc_id: 916150
cord_uid: zrg2z17n

nan

J o u r n a l P r e -p r o o f 2 | P a g e Vitamin D deficiency is a major global public health problem in all age groups [1] . It has been estimated that in excess of one billion people worldwide have vitamin D deficiency [2] .

Very few foods naturally contain vitamin D; dermal synthesis is the major source of the vitamin.

Vitamin D 3 is synthesized non-enzymatically in skin during exposure to ultraviolet B (UVB) radiation in sunlight. Vitamin D 3 is inactive and requires enzymatic conversion in the liver and kidney to form the active form, 1,25-dihydroxyvitamin D. Increased skin pigmentation reduces the efficacy of UVB because melanin functions as a natural sunblock. In addition, aging decreases the ability of the skin to produce vitamin D 3 [3] . During the winter months at latitudes of greater than 40°, little or no UVB radiation reaches the surface of the earth. Therefore, residence at high latitude increases the risk of vitamin D deficiency during the winter. This is likely compounded by age and skin pigmentation. However, residence at low latitude does not guarantee adequate vitamin D levels. Social and cultural norms may limit sun exposure. Vitamin D deficiency is particularly common in Middle Eastern girls and women [1] . Furthermore, despite abundant sunlight throughout the year in Ecuador, vitamin D deficiency was reported to be common among elderly women [4].

Vitamin D is a pluripotent hormone that modulates the innate and adaptive immune response [5] . Vitamin D influences several immune pathways, with the net effect of boosting mucosal defenses while simultaneously dampening excessive inflammation [6, 7] . Vitamin D deficiency is a risk factor for and/or a driver of the exaggerated and persistent inflammation that is a hallmark of acute respiratory distress syndrome (ARDS) [8, 9] . Vitamin D deficiency has been associated with an increased risk of respiratory infections such as respiratory syncytial virus infection, tuberculosis and influenza [10, 11] . The winter incidence of influenza closely correlates with seasonal serum vitamin D levels [12] . In a meta-analysis of randomized controlled clinical trial, J o u r n a l P r e -p r o o f 3 | P a g e Bergman and colleagues demonstrated that prophylactic vitamin D reduced the risk of developing respiratory tract infections (OR, 0.64; 95%; CI, 0.49 to 0.84) [13] . In this study, the optimal dose was between 1,000 IU to 4,000 IU/day and the benefit was greatest in those living at latitudes greater than 40 o . Vitamin D deficiency likely adversely affects the outcome of viral infections. Grant and Giovannucci reported a strong inverse correlation between UVB dose and the case fatality during the 1918-1919 influenza pandemic [14] . As vitamin D deficiency enhances the cytokine storm [6, 7] Furthermore, the cumulative summary case fatality rate was significantly greater for Northern states (> 40 o latitude) as compared to Southern States (6.0% vs. 3.5%, P< 0.001). However, this association is imperfect, with some Northern Sates (i.e., Wyoming and South Dakota) having low mortality rates while Louisiana has a high rate. Additional factors, such as racial makeup, population density, adherence to social distancing, use of vitamin supplements, and access to quality medical care, etc., likely play an additional role in explaining these geographical variations. In addition, we have assumed that the difference of test methods and statistics of all states are statistically insignificant; this assumption may not be entirely correct. [15] . Similarly, Daneshkhah and coworkers demonstrated that the age-specific case fatality rate of COVID-19 was highest in Italy, Spain, and France, European countries with the highest incidence severe vitamin D deficiency [16] . Our findings suggest that vitamin D deficiency may partly explain the geographic variations in the reported case fatality rate of COVID-19, implying that supplementation with vitamin D may reduce the mortality from this pandemic. However, as commonly suggested in the lay press, high-dose vitamin D appears to have a limited role in the treatment of patients with severe COVID-19 disease. The National Heart, Lung, and Blood Institute (NHBLI) performed a randomized controlled trial evaluating the role of high dose vitamin D (single dose of 540,000 IU of vitamin D 3 ) in critically ill patients who were vitamin D deficient (25-hydroxyvitamin D level < 50 nmol/l) [17] , the study failed to demonstrate any benefit from high dose vitamin D. This implies that higher doses than common recommendations are not supported by clinical evidence at present; therefore we advise a vitamin D dosage at what would be considered a standard nutritional supplement that may be sufficient in providing clinical benefits. Additional studies are required to further validate our hypothesis and translate this into an effective intervention for COVID-19.

The authors have no conflict of interest to declare.

Is vitamin D deficiency a major global health problem

Worldwide vitamin D status

Aging decreases the capacity of human skin to produce Vitamin D3

Immunomodulatory effects of Vitamin D in influenza infection

Calcitriol [1, 25[OH]2 D3] pre-and posttreatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells

The effect of inflammatory cytokines and the level of vitamin D on prognosis in Crimean-Congo hemorrhagic fever

Vitamin D deficiency conributes directly to the acute respiratory distress syndrome (ARDS)

Vitamin D deficiency and acute lung injury

Vitamin D status has a linear association with seasonal infections and lung function in British adults

Epidemic influenza and vitamin D

Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey

Vitamin D and respiartory tract infections: A systematic review and meta-analysis of randomized controlled trials

The possible roles of solar ulraviolet-B radiation and vitamin D in reducing case fatality rates from the 1918-1919 influenza pandemic in the United States

Editorial: low population mortality from COVID-19 in countries south of 35 degrees North -supports vitamin D as a factor determining severity

The role of vitamin D in suppressing cytokine storm of COVID-19 patients and associated mortality

Early high-dose vitamin D3 for critically ill, vitamin D-deficient patients